4.8 Article

Cyclosporine A-loaded and stem cell-seeded electrospun nanofibers for cell-based therapy and local immunosuppression

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 156, Issue 3, Pages 406-412

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2011.07.022

Keywords

Poly(L-lactic acid); Nanofibers; Cyclosporine A; Inflammation; Immunosuppression

Funding

  1. Grant Agency of the Academy of Sciences of the Czech Republic [KAN200520804]
  2. Grant Agency of the Czech Republic [P304/11/0653, P301/11/1568, 310/08/H077]
  3. Ministry of Education of the Czech Republic [1 M0506, MSM0021620858]
  4. Academy of Sciences of the Czech Republic [AVOZ50520514]

Ask authors/readers for more resources

Cyclosporine A (CsA), a potent immunosuppressive drug with low water solubility, was dissolved in poly (L-lactic acid) (PLA) solution, and nanofibers were fabricated from this mixture by electrospinning technology. The addition of CsA into the PLA solution and the conditions of the electrospinning process did not influence the structure of the nanofibers nor affect the pharmacological activity of CsA. Study of the CsA release behavior in culture medium showed a release for at least 96 h. After the topical application of CsA-loaded nanofibers on skin allografts in vivo, the release was significantly slower and about 35% of the drug was still retained in the nanofibers on day 8. The addition of CsA-loaded nanofibers into cultures of mouse spleen cells stimulated with Concanavalin A selectively inhibited T cell functions; the activity of stimulated macrophages or the growth of non-T-cell populations was not suppressed in the presence of CsA-loaded nanofibers. The covering of skin allografts with CsA-loaded nanofibers significantly attenuated the local production of the proinflammatory cytokines IL-2, IFN-gamma and IL-17. These results suggest that CsA-loaded electrospun nanofibers can serve as effective drug carriers for the local/topical suppression of an inflammatory reaction and simultaneously could be used as scaffolds for cell-based therapy. (C) 2011 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available